Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Markman

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Pain Medicine (Malden, Mass.)|March 25, 2015
Interpretation of urine drug testing results in patients using transdermal buprenorphine preparations for the treatment of chronic noncancer painJohn D Markman, William A Barbosa, Jennifer S Gewandter, et al.
Pain|January 15, 2021
Composite outcomes for pain clinical trials: considerations for design and interpretationJennifer S Gewandter, Michael P McDermott, Scott Evans, et al.
Neurosurgery|April 30, 2019
Association Between Opioid Use and Patient-Reported Outcomes in a Randomized Trial Evaluating Basivertebral Nerve Ablation for the Relief of Chronic Low Back PainJohn D Markman, Alfred L Rhyne, Rick C Sasso, et al.
Pain and Therapy|August 13, 2022
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 TrialJohn D Markman, Thomas J Schnitzer, Serge Perrot, et al.
Pain|January 10, 2019
Extended-release gabapentin for failed back surgery syndrome: results from a randomized double-blind cross-over studyJennifer S Gewandter, Maria E Frazer, Xueya Cai, et al.
Pain Management|November 17, 2021
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety studyShin-Ichi Konno, Takuya Nikaido, John D Markman, et al.
The Clinical Journal of Pain|February 22, 2023
Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis: A Mediation-Modeling ApproachLucy Abraham, Robert H Dworkin, Dennis C Turk, et al.
Neurology|September 11, 2015
Evaluation of outcome measures for neurogenic claudication: A patient-centered approachJohn D Markman, Jennifer S Gewandter, Maria E Frazer, et al.
Neurology|December 16, 2014
Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudicationJohn D Markman, Maria E Frazer, Shirley A Rast, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision MedicineJennifer S Gewandter, Michael P McDermott, Hua He, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Pain Medicine (Malden, Mass.)|March 25, 2015
Interpretation of urine drug testing results in patients using transdermal buprenorphine preparations for the treatment of chronic noncancer painJohn D Markman, William A Barbosa, Jennifer S Gewandter, et al.
Pain|January 15, 2021
Composite outcomes for pain clinical trials: considerations for design and interpretationJennifer S Gewandter, Michael P McDermott, Scott Evans, et al.
Neurosurgery|April 30, 2019
Association Between Opioid Use and Patient-Reported Outcomes in a Randomized Trial Evaluating Basivertebral Nerve Ablation for the Relief of Chronic Low Back PainJohn D Markman, Alfred L Rhyne, Rick C Sasso, et al.
Pain and Therapy|August 13, 2022
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 TrialJohn D Markman, Thomas J Schnitzer, Serge Perrot, et al.
Pain|January 10, 2019
Extended-release gabapentin for failed back surgery syndrome: results from a randomized double-blind cross-over studyJennifer S Gewandter, Maria E Frazer, Xueya Cai, et al.
Pain Management|November 17, 2021
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety studyShin-Ichi Konno, Takuya Nikaido, John D Markman, et al.
The Clinical Journal of Pain|February 22, 2023
Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis: A Mediation-Modeling ApproachLucy Abraham, Robert H Dworkin, Dennis C Turk, et al.
Neurology|September 11, 2015
Evaluation of outcome measures for neurogenic claudication: A patient-centered approachJohn D Markman, Jennifer S Gewandter, Maria E Frazer, et al.
Neurology|December 16, 2014
Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudicationJohn D Markman, Maria E Frazer, Shirley A Rast, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision MedicineJennifer S Gewandter, Michael P McDermott, Hua He, et al.
Pageof 6